Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil. [electronic resource]
- Genetics and molecular biology 05 2016
- 210-22 p. digital